Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats
- Gen Pharmacol. 1999 Mar;32(3):299-305. doi: 10.1016/s0306-3623(98)00180-3.
- 1. Research Division, The Green Cross Corporation, Osaka, Japan. [email protected]
We investigated the protective effect of chronic treatment with AE0047, a dihydropyridine-type Calcium Channel blocker, on vascular endothelial abnormalities in stroke-prone spontaneously hypertensive rats (SHRSP). Ten-week repeated antihypertensive treatment with AE0047 inhibited blood pressure elevation and improved endothelium-dependent relaxation in response to acetylcholine in aorta isolated from SHRSP. Furthermore, the abnormal production of prostaglandin I2 and thromboxane A2 in the aorta was normalized to a level equivalent to that in Wistar-Kyoto rats. These results suggest that chronic treatment with AE0047 exerts protective effects against endothelial abnormalities associated with the development of hypertension.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Calcium ChannelResearch Areas: Cardiovascular Disease